Ticlopidine versus aspirin after myocardial infarction (STAMI) trial (Q28181674)

2

0 references

E Marubini

3

0 references

M V Pitzalis

4

0 references

M Di Biase

5

0 references

P Rizzon

Journal of the American College of Cardiology

6

0 references

language of work or name

English

0 references

publication date

April 2001

0 references

published in

0 references

volume

37

0 references

issue

5

0 references

page(s)

1259-65

0 references

cites work

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Oral inhibitors of platelet membrane receptor glycoprotein IIb/IIIa in clinical cardiology: issues and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Differential Suppression of Thromboxane Biosynthesis by Indobufen and Aspirin in Patients With Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Ba

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Reocclusion: the flip side of coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Optimal management of acute myocardial infarction at the dawn of the next millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Blood flow and antithrombotic drug effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

Platelet inhibitor agents in cardiovascular disease: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021

ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901164-0

7 January 2021